DSIpharma, Inc. — Form D
DSIpharma, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-15. The offering totals $500K, of which $45K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2025-07-15
- Form: D
- Accession: 0002076369-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $45K
- Remaining: $455K
- Investors: 1
- Date of first sale: 2025-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-551710
Issuer
- Name: DSIpharma, Inc.
- CIK: 0002076369
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 251 LITTLE FALLS DRIVE, WILMINGTON, DE, 19808
- Phone: 866-403-5272
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Kysha Ayana Pierre-Louis | Director | Wilmington, DE |
| Mark Ridall | Director | Wilmington, DE |
| Kysha Ayana Pierre-Louis | Executive Officer | Wilmington, DE |
| Mark Ridall | Executive Officer | Wilmington, DE |
More